Not only was drug therapy usually required, the need for escalating polypharmacy in the pursuit of glycaemic targets was also amply demonstrated . Continuing loss of function of function of islet B cells is held to be the major determinant of the slowly progressive hyperglycemia that characterizes type 2 diabetes, although other factors such as weight gain and/or failure of compliance with dietary pre- sacriptions may also contribute.